GVRP and Yurogen Biosystems partner to enhance biologics drug discovery in India

image credit- freepik

Hyderabad-based GV Research Platform (GVRP) has announced a strategic distribution partnership with US-based Yurogen Biosystems, a global life sciences company specialising in custom biologics development.

The collaboration is aimed at expanding access for Indian biotechnology and pharmaceutical companies, as well as academic research institutions, to advanced antibody discovery capabilities supporting early-stage drug discovery and translational research.

Under this partnership, GVRP will serve as the commercial interface for Yurogen Biosystems in India, enabling streamlined market access, client engagement, and program coordination, while all scientific execution and service delivery will continue to be carried out by Yurogen Biosystems.

The collaboration responds to the growing demand within India’s life sciences ecosystem for globally benchmarked antibody discovery services, particularly in areas requiring deep biological insight at early stages of research. By combining Yurogen’s scientific expertise with GVRP’s understanding of the Indian research ecosystem, the partnership enables smoother and more efficient engagement for domestic innovators.

The partnership will provide access to Yurogen Biosystems’ proprietary SMab™ single B-cell technology, enabling rapid generation of high-affinity monoclonal antibodies to support early discovery and translational research programmes.